Warning: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in ..../includes/class_bbcode.php on line 2958

Warning: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in ..../includes/class_bbcode.php on line 2958

Warning: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in ..../includes/class_bbcode.php on line 2958

Warning: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in ..../includes/class_bbcode.php on line 2958

Warning: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in ..../includes/class_bbcode.php on line 2958

Warning: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in ..../includes/class_bbcode.php on line 2958

Warning: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in ..../includes/class_bbcode.php on line 2958

Warning: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in ..../includes/class_bbcode.php on line 2958
- 33


33 37 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37
321 330 366

:

  1. #321
      bode
    Jun 2007
    2,818


    : . 7.1 4.8 . ǡ " ". .

    2008 7300 . 2008 12.7 7.6 2030.


    : 150 . . 460 2008 610 .

    150 18 60 5 17 " ".

    . ǡ 23 62 670 60 . 2005 .


    : . ' ɡ 3 5 ' ' 4 '. '' . .

    7

    . 15

    " " .. .. . 700 .

    ..

    : . " " ɡ .

    " ".

    . .

    : 1.3 2011

    1.3 . .

    . - ( ) - : " " .

    - ( Annals of Oncology) 281466 2011 256001 2007 . . 15 .


    ɡ ѡ . ɡ () ǡ "" . ѡ ɡ " " (Gamma Knife) " " (Cyber Knife). " " "" . ǡ . " " .

    ͡ " " ɡ 3 8 ӡ ѡ " " ʡ . ǡ " " ( ). " " ۡ ɡ .


    ɡ ϡ ȡ 165 . ɡ . ɡ ˡ .

    ɡ ɡ . ѡ ֡ ǡ !

    ߡ . ֡ ݡ ɡ " " (Endothelin-1) .

    ϡ ϡ " " "" (Zibotentan). ϡ ֡ "" (paclitaxel) " (Carboplatin). 3 ɡ !


    : . ' ' 6 50' 7 .

    ' . ' . '' 1240 338 6 .



    . ˡ ɡ .

    91% . 405 1983 2004 37 ɡ ǡ .

    ֡ 91% 84 %. ͡ . .

    800 250 .



    * ӡ . . . :

    * ѡ .
    * .
    * . .
    * ɡ ڡ .
    .
    * .
    * .


    ǡ ɡ "" . .

    ɡ . " " " ".

    ѡ ޡ :" . ".

    ǡ ɡ . 21 ɡ 100 ȡ .

    ɡ . :" ".

    ǡ ҡ :" ǡ . . ".


    . ߡ . ɡ 2004. ʡ .

    ̡ () ɡ ɡ ɡ ̡ ǡ .

    ѡ (Cork Cancer Research) ѡ (EndoVe) (Endoscopic Device Targets Colorectal Tumors) (Cliniporator) "" .

    . ̡ ѡ . ɡ . ǡ ɡ ǡ ɡ ֡ .



    14 2001. "" 64 . ߡ ɡ . . .

    ֡ . ߡ ֡ . . . . ֡ . .

    "" ֡ ɡ . "" .

    ɡ ֡ "". . ߡ ֡ ɡ 2 3 .
    bode ; 21-Feb-2011 05:06

  2. #322
      bode
    Jun 2007
    2,818

    Medical


    . ǡ . . . .

    :

    : 2009 3.5 % 4815 . 296 ɡ 256 . " 926 ɡ 264 " 19 % 12 % 8 %.


    10 %

    9.5٪ ɡ " " .

    .

    " " ѡ .

    ( ) 2009 5000 70 20 ) "" " " 200 .

    ... 43 %

    "" "" ʡ ɡ 30 9.5٪ .

    ɡ ɡ ѡ . .

    78 2010 1181 671 63 90%.

    2009 13,981 1,542 1,324 1,103 2010 1181 . 2007 2009 35% 30% 55% 43%. 2008 1,221 2009 1,324 .

    ..

    "" " " " " " "

    350 .

    :" () " " " .

    25 " " . ǡ 100 28 .


    " " .

    12 .

    ʡ .



    . ɡ .

    ǡ ǡ ǡ ɡ . ɡ . . ɡ 1980 2008 20 ɡ 145 ( 82 ) 731 721 .

    . 2009 210930 358953 29 . 200 300 75 . ǡ ͡ .

    Zytostatika ǡ . Avastin Novartis Lucentis.

    . 24 ( ) ɡ N1 ۡ . .

    ѡ . ɡ ֡ ultraschal-diagnostic . ɡ .

    8


    " . " " ɡ " ". ɡ :" .

    /


    . . ( ) . 8000 ( ) 4000 .

    ϡ ɡ 100% 50% . 53% 23,5 ѡ 12,3 .

    ϡ ɡ :" ǡ .

    :" .

    .


    :" .

    30


    30 ɡ 200 15 ɡ 20 . . 3 ɡ 38 40 ɡ 8 . ǡ . ء ɡ ʡ ѡ ̡ .

    "" . "". .

    ա ȡ ѡ . " ǡ ̡ ". " ֡ ". ǡ ɡ ޡ . " ɡ ɡ ̡ " " ".

    ɡ . " ʡ ϡ ѡ ". " ϡ ǡ ǡ ɡ ". " ǡ ǡ ". ɡ .

    ʡ . " ա ". " " " ա .. ". 90 . .


    40

    :

    40 ѡ ʡ . ɡ "" . ɡ 50.3 49.7 83.4 85.9 .

    9541 (29%) 3561 ǡ 1612 (10.5%) 1482 (7.1%) 737 (4.8 %). ǡ ѡ . 1681 (12.3 %) 1180 (8.6 %) 1169 (8.5 %) 1005 (7.3 %) 942 (6.9 %).

    8706 6093 ( ) 4202 ɡ .


    5 1267 15 ǡ 748 (59%) 519 (41 %) 23.4 16.9 .

    ա . " " . ̡ .

    ɡ ( ) ( ) ȡ .


    ɡ ɡ : . . ˡ ɡ .

    ݡ 60 .

    ɡ () . "" .


    "" ڡ ɡ . " " " " !. " " ڡ . .

    " " " " . " " 40 ɡ 28 ء . ɡ " " ɡ " " .

    ǡ ɡ ϡ " " ɡ 1500 . ѡ .


    ѡ 80 90 ɡ 75 ɡ 50 60 .


    " " " " " " " " ѡ 85 ǡ . " " ֡ ѡ .

    / " " ʡ . " " ɡ .


    ʡ . " " ɡ . ʡ ɡ " " ɡ .

    ɡ ǡ "" . "" " " 2004. " " ɡ " " .

    . " " ڡ . ɡ 10 15 20 ɡ ɡ .



    . 400 100 300 100 ˡ 100 ɡ .

    ȡ ɡ ɡ ֡ ɡ ѡ .

    ˡ ѡ ֡ ڡ .

    . ڡ ɡ ۡ ̡ . "" ֡ ̡ . " . ɡ . ʡ . ǡ ".

    :" ɡ ɡ . ȡ ɡ ɡ ".


    . . . . " ".

    45 2007 2030 ( 7.9 11.5 ) (11.3 2007 15.5 2030). . " " .

    (1999-2008) 5019 (1659 ) (3360 ). 24 40 60 . 175 2008 96 79 . " " 60 .. .

    . " " 60 . 18 15-20 39.5 21-30 27.2 31-40 12 41-50 3.1 . 37.6 61.1 1.3 .

    35 .

  3. #323

    Feb 2011
    12

    :


  4. #324
      bode
    Jun 2007
    2,818

    Medical





    ( ) (ɡ ѡ ) ( ʡ brachytherapy ɡ ). ǡ ϡ ɡ ɡ .

    ǡ . ء (androgen-deprivation therapy). ɡ 仡 .

    prostate specific antigen (PSA) . ǡ . ١ Ȼ . 27 .

    .

    *

    * ǻ (prostate cancer vaccine) ѡ . . . . . .

    ϡ ѡ (antigen) . ǡ ȡ . ݡ (androgen-independent prostate cancer cells). ɻ.

    *

    * ̻ (Provenge) ( - sipuleucel-T). ʻ (antigen processing cells) (APCs) ɻ () dendritic cells ɻ (macrophages). ɡ . ʻ costimulatorymolecules .

    . ̻ prostatic acid phosphatase (PAP) ǡ . . - granulocytemacrophage colony stimulating factor (GM-CSF) ʻ .

    . ʻ leukapheresis. ʻ (Dendreon) ̻. ʻ (PAP) (GM-CSF) . ǡ . . . ʻ (PAP) - .

    *

    * ̻ . 2010 IMPACT.

    IMPACT 2003 512 . ̻ . ̻ 21 . ɡ ߡ ̻ 4.1 (25.8 21.7 ). ̻ ɡ ɡ . 3.5 (2.5 ) . ǡ ɡ 32 ̻ ɡ 23 .

    *

    * ̻ ѡ . ɡ . . ܫ̻ 93 . IMPACT ɡ ̻ (docetaxel) (ѻ (Taxotere .

    ǡ ء . ̻ . .

    ̻ . . . .
    * ỡ ǻ



    . ɡ .

    ɡ ɡ .

    ‫ . ӡ ɡ .



    ϡ 500 270 .

    ɡ .

    20 .
    ϡ ɡ .

    ʡ .

    150

    ɡ 150 ڡ . ( ) " ".

    2008 460 610 . "" ɡ 150 18 ѡ 60 5 17 ǡ .




     .

    - . .

    . . .

    . . . .

    : .

    :

    .
    .
    . .



    20 . 20 . . .

    . ʡ ɡ ӡ .

    . . . .



    ѡ .

    80% 4% ɡ .

    ޡ - 45% - 25% 30% 2 5 ѡ . ɡ 100 ɡ 2500 -3000 500 .

    : ա .

    ɡ ɡ ɡ .

    ϡ ڡ ʡ . ɡ ڡ .




    ...


    70% 2009 13000 15-20% 300 ڡ 800 1200 .

    73198 .

    120 30% .

    ɡ .



    /150/

    ӡ . ޡ ɡ ɡ .

    150 . 1982 1997 1998 2005 1998 2006.

    10 . :" ۡ ".






    ɡ ǡ . ǡ / 2008 . . " " " ǡ " " ǡ ".

    " ǡ / 2009 2 ɡ " " ޡ ".

    ɡ 16 ֡ ѡ . ֡ - ɡ 2008. ǡ ɡ .

    ɡ ɡ .

  5. #325
      bode
    Jun 2007
    2,818

    Medical


    . "" 10 . .

    ݡ 669 388 281 . .

    . 5% 9.5% . " ".

    . "" . .



    ( ) 95 .. " " . . / .. .

    ( ) .. 80 90 40 .

    2 5 .. . : " .. " .

    ( ) ( ) ( ) / : .. .

    (HPV) 350.000 520.000 (Who) .. : " 11 15 44 1.3 100.000 152 55 309 117 2025 ʡ " .

    3.4 100.000 143 2.2 100.000 108 .


    :

    .. . - ( ) - : .. . - - : " ( 2) ( 4) " .. : " " .

    ( 4) 16 130 . - () - . ( 4) ( ) " " .


    . .

    . . 500 31 .


     9 1 8 . 2008 48% 50 69 -- . 33% 70 ɡ 25 -49 19%. ( . . " -- .

    . "" ɡ .

    20 . 10 .


    ǡ 28000 . ɡ ֡ . 10 40 . . " ̡ ʡ .


     - . 100000 1998 2006 . 8% . ( 37 ٪) . . 50%.

    10 30

    10 30 . 100 % 15 %. 2009 914 .

    %95
    ..

    ٻ 95 ɡ ɻ. .


    . ѡ ɡ 80 90 40 ɡ .
    2 5 ѡ . ɡ ɡ ɡ .


    ʡ ɡ .

    (HPV) 350.000 520.000 (Who) 11 ɡ 15 44 1.3 100.000 152 55 309 117 2025 ʡ .

    3.4 100.000 143 ǡ 2.2 100.000 ɡ 108 ǡ ʡ .


    ֡ ߻ ߡ ɡ . ѡ ɡ ɡ ɡ ɡ ɡ . .


    2011 .

    ɡ . .



    - 120 100

    : 75 100 , 83479 , 73198 ʿ!.. , .


    20% , 80% ѿ!.. .

    , 73198 ɡ , 120 100 30% .. 2002-2007 4635 12% 996 .

    11064 5836 5613 , 5354 4483 4431 3945 3928 3347 3198 2825 2689 , .

    .. 63 75 100 105 100 : , 2007 2009 13000 15-20% , " " 300 800 1200 .

    . .

    ɿ

    , ޡ ɡ ʡ .. .


    St . Michael's Hospital ɡ ( ) . .. .. : .

    . - - ( ) ( ) 65% .

    . .


    ..

    ɡ . ʡ ʡ .

    ɡ ɡ ȡ . ɡ " " " " .


    " " ֡ " " . " " ɡ .


    . . ɡ . . . ǡ ǡ ǡ " ".


    "" . " " . . "" "" .

    "" . . ɡ ɡ . ɡ .

    "" "" . ɡ ɡ . ǡ 20% .


    "" "" . . ǡ . ʡ . ɡ .


    - . . .

    - . . . . 6 .

    - . 50 80 . 25% .


    - : "" ɡ . .

    . ɡ ɡ .

    - : "" . ɡ ϡ ϡ ɡ .


    30% . . 7 ʡ ǡ :

    - . ȡ "" . " " "" "" .

    - "" "". "" "" "" . "" " " . "" "".

    - . . "" "". "" "". "" "" "".

    - . "" "". " " . "" "" "" "" "" "" .

    - . " ".

    - ʡ "".

    - ɡ "" "". "" "" "" "".

    - ɡ "" "" . "" . "" .

    - "" .


    . 17 ѡ . .

    200 ʡ ɡ . 73 ɡ 20 35 ɡ .


    . . ȡ "" .


    6% 6.3% 70% . ɡ ɡ "FDA" .


    . . ɡ ݡ . ء . .



    : . ʡ 70 ڡ . ɡ " ".

    . .

    ɡ . ϡ .


    : . .

    ѡ " ".

    50 8 6/11 . . .

  6. #326
      bode
    Jun 2007
    2,818

    Medical

    40

    .

    100 ɡ 23% 55% . ߡ 53 40 ɡ ̡ . .

    : " ڡ ". : " ".

    . : " ʡ ֡ ɡ ".

    ɡ 4000 6000 ɡ 40 .



    . 3.1% . ɡ .

    ǡ ɡ . ɡ 20 ͡ () () ϡ .

    ɡ . ɡ .



    . . 28.000 . .

    . . 1987 Ρ .

    ֡ ". . .


    . ߡ . ɡ 2004. ʡ .

    ̡ () ɡ ɡ ɡ ̡ ǡ .

    ѡ (Cork Cancer Research) ѡ (EndoVe) (Endoscopic Device Targets Colorectal Tumors) (Cliniporator) "" .

    . ̡ ѡ . ɡ . ǡ ɡ ǡ ɡ ֡ .


    100 2 ء . ȡ . ޡ . ڡ "" .

    ʡ "" . "" (Nilotinib) .

    ɡ ǡ ʡ ɡ ɡ . ʡ ǡ .

    800 1

    1000
    - 22. 6
    - :

    2741 ɡ 800 . 22. 6 ɡ 19. 4ɡ 19. 1ɡ 17. 5ɡ 12. 6. 11. 7ɡ 11. 5ɡ 11. 3ɡ 10. 6ɡ 9. 0ɡ 6. 3ɡ 5. 7 2. 2ɡ 48 50 .


    10 15 ѡ 30 2212 40 253 50 54 60 23 70 14 12 30 .


    3 ɡ . .. ա ɡ ɻ.


    2 2 - 5 5 .


    ǡ ɡ .. " ǡ ǻ.


    1 .

    ɡ . 98 15 50 ֡ 1000 8 .


    .

    : 8 12 8 ɡ .


    38 6 20 12 14 ǡ 34 : ɡ ϡ ɡ ϡ .


    5 8 37.. : 5 ѡ ɡ ɡ ɡ ɡ ɡ ɡ 6 ǡ ߡ ̡ ʡ ɡ 3 ϡ ɡ ɡ .


    1000 2015 .

    24
    " "

    ɡ ɡ . "" ֡ ǡ .

    " " 18 ɡ ɡ ɡ ϡ '' '' '' " .

    ɡ ȡ ɡ ɡ ʡ .

    (1600 ) ߡ .

    ɡ ɡ " " .

    ɡ . 85 ɡ 5 10 ѡ ɡ ա .

    30 ǡ ɡ ɡ ǡ ʡ .

    .

    ɡ ǡ " " ɡ .

    ɡ " " " " .

    " " ѡ ȡ 13 . ɡ .

    ɡ ɡ .


    1960 . ( ) .

    ǡ (74 ) ɡ ɡ 650 .

    " ʡ ѡ 30 .

    :" ʡ ϡ ɡ ɡ .

    "" "" ǡ 13 / 1960 16 / 1966 42 .

    ɡ 24 ɡ .
    bode ; 01-Mar-2011 10:37

  7. #327
      bode
    Jun 2007
    2,818

    Medical


    . ɡ . ɡ . ɡ "".

    ɡ ϡ " " ϡ "" (iniparib) ɡ (HER2) .

    ɡ "" (PARP) (polyADP-ribose polymerase) . "" "".

    ϡ ɡ . . .




    ‫ . ‫ ֡ ȡ .

    ‫ 18% 4% . 111,140 ɡ ա 1976 2006 36,017 1982 2006. 8,772 .

    25 ‫ ‫ . ‫ ʡ : " ɡ ".


    .

    ‫ . ‫‫ ʡ . ‫ ɡ 4000 6000 ɡ 40 .


    11%

    11 . 3000 ɡ 11 .

    . . : " . ."

    . . ɡ . .

    . . . , ѡ ʡ .

    . ɡ ɡ . . .

    . : " ɡ . . ."


    ..

    . 6,000 . 200,000 .

    " ," . . 70% 50% ֗ ( ).

    . -- 6,322 . 68 .

    . . .

    ǡ 600 . .

    92 4 6 . . 65 .

    ."

    !

    "" . ʡ "" "" . ڡ ɡ .

    . ! 15 20 . . ϡ ǡ ʡ ӡ ɡ . ɡ ա "" ɡ .

    ϡ . (stromal cells) . ɡ . ɡ . "" . ʡ ȡ "" !



     ޡ 58 . ɡ .

    ǡ ա ѡ ɡ .

    1953 1987. 2004 2008 ڡ 50 1303 13 1768. .

    ڡ 575 .


     . , , .

    , .

    " " , , .

    , ,,, , .

    .

  8. #328
      bode
    Jun 2007
    2,818

    Medical


    : . "" 152 . .

    :

    : . "" . .



    : . " " " " - - " " " ".

    . .



    10

    03-03-2011 ɡ .

    : " " . "" ( ) 28 / 2009 ɡ ǡ .

    20 30 . ɡ ɡ ڡ .

    4.6 %
    :
    -

    ɡ . . : " ". ء ɡ .

    97 820 25 ɡ . ǡ 2050 .

    ǡ ɡ . : " ". . ɡ 280 4.6 ֡ .


    . 16% 30% . . ɡ .

    . . ɡ "" .

    . 38000 . 16 ٪ 35 ٪ . .

    1 4 50 2 4 70 ..
    :


    : . " " . ʡ " " " ". " ". " " . ޡ 5 .


    ()

    . () 4000-8000 () (1) . 4000 .


    ɡ ɡ . . "" (heterotaxine) !

    ߡ ɡ ȡ . "TGF-beta" (Transforming Growth Factor Beta) "" "" . ɡ ǡ . ѡ . ߡ . "" . . ϡ ʡ ȡ !


    , regulatory RNA"" . ɡ . , .





    (molecule) "" . . . ɡ (miR-200c) ɡ .

    ɡ (miR-200c) " " " " (micro-Rna). (miR-200c) . ʡ ֡ . ݡ "" . (miR-200c) ֡ . .

    ǡ . 30 40 . 60 .

  9. #329
      bode
    Jun 2007
    2,818

    Medical


    . 30 . 21 ٪ 41 ٪ . .

    :


    .
    .

    6500 50.


     ɡ . ɡ ֡ ɡ ʡ .

    115 (48 ٪) ա (11 ٪) ɡ 31 ٪ . . .



    1975. 88 1975 190 2008. 273 2008 1975.

    . 1975 . 41 . " ".
    :


    ""

    : "" . " " ǡ " ".

    1238 1238 "" ɡ . ̡ . ̡ .



    . . 1979 1987. . ..



    . . . .


    .

    . . 261 . ..


    . 59 . 58 ٪ . ..


    : ɡ . " " .

    850 12 ɡ . 10% . 3 . .

    1.61 .


    : ɡ . , , . .

    , . , .


    610 2008


    . ǡ . ۡ . 610 2008 . ߡ .

    3% . ߡ 416% ɡ 1686 2008.

    ɡ 6807 42 2001 2005. 2006 . .

    : " ɡ ѡ ". 10 . ɡ 90% . ۡ .

    20% (80%) ɡ ɡ . ɡ ɡ 50 60% . " " " ". ɡ .

    ߡ ۡ 10 ѡ . ( ). " " .

    : " . ߡ ѡ ". 10 . ߡ ۡ .

    500 1000 ѡ . : " 10 . 10 . ".

    , " " " ". . .

    ( ). " " . " . ". .

    . ֡ .


    " " ɡ :

    - .
    - ɡ .
    - .
    - .
    - .


    :

    - ( ).
    - .
    - .

    () ().


    . ɡ ɡ ɡ . ֡ ݡȡ ǡ "".


    ɡ :

    - .

    - : ʡ ɡ ɡ .

    - : .

    - : .

  10. #330
      bode
    Jun 2007
    2,818



    1970 . 4700 60 2008 1975 800 60 . .. 1975 23400 2008 19400 .

    . . ..


    . . " ".

    77000 . , .

    ..

    : .
    . (GEP) (DNA Microarray) (HER2). (trastuzumab).

    (trastuzumab) . (Basal like Breast Cancer).

    *

    * () ɡ ǡ .

    2 (HER2). .

    . (Personalized Therapy) .

    *

    * ѿ . (HER2) .

    *

    * (BRCA1) (BRCA2) . . .

    (BRCA1) (BRCA2) 15 85 . (BRCA1) (BRCA2) .

    ɡ 42 ɡ 15 .

    *

    * . (Adjuvant Therapy) (Neoadjuvant Therapy) (Complete Pathological Remission) .

    (BRCA1 BRCA2) ѡ (DNA). ɡ (BRCA1 BRCA2) .

    *

    * (Bevacizumab) (Cetuximab) (VEGF) (EGFR) . (BRCA1 BRCA2) .

    *

    * . (BRCA1 BRCA2) (Homologous Recombination) .

    (PARP) . .

    (PARP Enzyme Inhibitors) (Base Excision Repair) (Synthetic Lethality) . (iniparib) (olaparib) . 23 52 (PARP) (iniparib) ɡ (iniparib) . ʻ (PARP) (olaparib) (BRCA1 BRCA2) .

    (PARP) ɡ .




    : *
    ɡ ǡ ̡ . Ǻ ʡ 51 ߡ ֡ . . ʡ ǡ .


    * () (human papillomavirus (HPV 80 90% ̡ . . ! 27 : ջ. ѻ. : ǻ.

    16 18 ӡ HPV 16 and 18 . ( ) ỡ . ʡ ޻ () .


    * 3 25 ǡ 23 ǡ ̻. ӡ ӡ . .

    analcancerfoundation.org .

    : ( ) ǻ. . ̺ . : ̡ Ǻ . ̿.


    * ۡ : 50 60 ֻ. ʡ һ ߺ 2009. : ǻ.

    ѡ 3260 2000 . ɡ Ϻ 2% 720. 16 18 . Ѻ : ѡ ߻.

    . . ɡ ɡ . : . ɡ Ȼ. . : ڻ.
    * һ

    ..

    : *
    85 . . 62 .

    :

    * ɡ . ɿ

    - ͡ . 1961 . 21. ǡ ϡ . .


    * 1961

    - ɡ ( ) . . ɡ 1960 . ʡ . .

    * ɿ

    ѻ. . ɡ . : . . Ȼ. .

    . .

    * ( ) chromosome translocations 1972

    - . . 1970 . . . . . ɡ .

    * ݿ

    - . . 8 21 . . 9 . . Ϻ 9 .

    * ɿ

    - . ϡ ɿ 1977 . . .


    * ߻ Gleevec . Ϳ

    - . ڡ . .

    *

    - ǡ . . ߻ . . ϻ . . ϡ .
    * һ

    ..

    ( ) ǻ ɡ . . . 5 .

    ɻ . : ( ) ϻ. . : ɻ .

    ѡ . ۻ ߡ . . . : ɻ . ϡ . .

    : ɻ. ɡ . .

    8 ʡ . . 10 . һ . ɡ : ɻ.

    ֡ һ . . . . : ǻ.

    . . .

    . : . . 24 . 10 . : ǡ .

  • " " ʪ , , Ӫ ʪ.
  • 17 2006 24 1427 , , , .
  • .
  • , .